Tamayo Louis Edward has filed 4 insider transactions across 1 company since August 2025.
Most recent transaction: a grant/award of 44665 shares of Lexeo Therapeutics, Inc. ($LXEO) on February 04, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | Lexeo Therapeutics, Inc. | $LXEO | Tamayo Louis Edward | Chief Financial Officer | A | Common Stock | 44665 | $0.00 | 89,665.0000 | 72,987,327 | 99.26% | 0.06% |
| Feb. 4, 2026 | Lexeo Therapeutics, Inc. | $LXEO | Tamayo Louis Edward | Chief Financial Officer | A | Stock Option (right to buy) | 226665 | $0.00 | 226,665.0000 | 72,987,327 | 9999.99% | 0.31% |
| Aug. 29, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Tamayo Louis Edward | Chief Financial Officer | A | Common Stock | 45000 | $0.00 | 45,000.0000 | 33,196,997 | 9999.99% | 0.14% |
| Aug. 29, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Tamayo Louis Edward | Chief Financial Officer | A | Stock Option (right to buy) | 280000 | $0.00 | 280,000.0000 | 33,196,997 | 9999.99% | 0.84% |